News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
80,472 Results
Type
Article (4708)
Company Profile (9)
Press Release (75669)
Section
Business (27954)
Career Advice (127)
Deals (4851)
Drug Delivery (8)
Drug Development (10879)
Employer Resources (13)
FDA (1759)
Job Trends (2515)
News (41219)
Policy (2800)
Tag
2027 Biotech Bay Standard (1)
Academia (188)
Accelerated approval (14)
ADA (16)
Adcomms (1)
Allergies (55)
Alliances (2900)
ALS (26)
Alzheimer's disease (274)
Antibody-drug conjugate (ADC) (97)
Approvals (1943)
Artificial intelligence (91)
ASCO (85)
Autoimmune disease (54)
Automation (4)
Bankruptcy (40)
Best Places to Work (1963)
BIO (13)
BIOSECURE Act (1)
Biosimilars (51)
BioSpace Insights (7)
Biotechnology (6)
Bladder cancer (54)
Brain cancer (12)
Breast cancer (165)
Cancer (1268)
Cardiovascular disease (116)
Career advice (126)
Career pathing (4)
CAR-T (57)
CDC (2)
CDMO (19)
Celiac Disease (1)
Cell therapy (160)
Cervical cancer (15)
Clinical research (10844)
Collaboration (234)
Commercialization (1)
Compensation (142)
Complete response letters (5)
COVID-19 (256)
CRISPR (25)
C-suite (70)
Cystic fibrosis (8)
Data (2205)
Decentralized trials (1)
Depression (27)
Dermatology (30)
Diabetes (155)
Diagnostics (983)
Digital health (9)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (48)
Drug pricing (12)
Drug shortages (3)
Duchenne muscular dystrophy (78)
Earnings (21802)
Editorial (4)
Employer branding (3)
Employer resources (12)
Events (14798)
Executive appointments (90)
FDA (2563)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (3)
Frontotemporal dementia (12)
Funding (188)
Gene editing (45)
Generative AI (4)
Gene therapy (116)
GLP-1 (201)
Government (407)
Grass and pollen (2)
Guidances (240)
Healthcare (2282)
Hematology (38)
HIV (15)
Huntington's disease (8)
IgA nephropathy (28)
Immunology and inflammation (46)
Immuno-oncology (10)
Indications (54)
Infectious disease (321)
Inflammatory bowel disease (47)
Influenza (24)
Intellectual property (25)
Interviews (20)
IPO (3165)
IRA (1)
Job creations (660)
Job search strategy (111)
JPM (8)
Kidney cancer (11)
Labor market (25)
Layoffs (118)
Leadership (3)
Legal (499)
Licensing (3)
Liver cancer (11)
Longevity (3)
Lung cancer (188)
Lymphoma (153)
Machine learning (4)
Management (2)
Manufacturing (139)
Marketing (2)
MASH (61)
Medical device (1775)
Medtech (1801)
Mergers & acquisitions (1891)
Metabolic disorders (343)
mRNA (29)
Multiple sclerosis (46)
NASH (2)
Neurodegenerative disease (73)
Neuropsychiatric disorders (9)
Neuroscience (511)
NextGen: Class of 2026 (684)
Non-profit (379)
Now hiring (6)
Obesity (130)
Opinion (18)
Ovarian cancer (55)
Pain (30)
Pancreatic cancer (57)
Parkinson's disease (58)
Partnered (3)
Patents (49)
Patient recruitment (86)
Peanut (15)
People (2579)
Peptides (1)
Pharmacy benefit managers (5)
Phase 1 (2491)
Phase 2 (4441)
Phase 3 (4824)
Pipeline (2984)
Policy (18)
Postmarket research (400)
Preclinical (768)
Press Release (3)
Prostate cancer (70)
Psychedelics (3)
Radiopharmaceuticals (51)
Rare diseases (184)
Real estate (508)
Recruiting (6)
Regulatory (2723)
Reports (14)
Research institute (193)
Resumes & cover letters (4)
Rett syndrome (6)
RNA editing (4)
RSV (19)
Schizophrenia (26)
Series A (27)
Series B (24)
Service/supplier (1)
Sickle cell disease (27)
Special edition (5)
Spinal muscular atrophy (21)
Sponsored (5)
Startups (315)
Stomach cancer (2)
Supply chain (14)
Tariffs (12)
The Weekly (7)
Vaccines (186)
Venture capital (14)
Weight loss (85)
Women's health (27)
Worklife (5)
Date
Today (18)
Last 7 days (96)
Last 30 days (386)
Last 365 days (5548)
2026 (3919)
2025 (5705)
2024 (5622)
2023 (5797)
2022 (6662)
2021 (6560)
2020 (5979)
2019 (5258)
2018 (4183)
2017 (4709)
2016 (3355)
2015 (3814)
2014 (2416)
2013 (1641)
2012 (1799)
2011 (2082)
2010 (1937)
Location
Africa (93)
Alabama (11)
Arizona (57)
Arkansas (2)
Asia (4357)
Australia (643)
California (2644)
Canada (624)
China (227)
Colorado (112)
Connecticut (102)
Delaware (115)
Europe (13365)
Florida (354)
Georgia (78)
Hawaii (2)
Idaho (6)
Illinois (214)
India (16)
Indiana (151)
Iowa (2)
Japan (157)
Kansas (7)
Kentucky (12)
Louisiana (18)
Maine (19)
Maryland (257)
Massachusetts (1977)
Michigan (49)
Minnesota (103)
Missouri (34)
Montana (3)
Nevada (15)
New Hampshire (10)
New Jersey (987)
New Mexico (5)
New York (723)
North Carolina (343)
Northern California (1371)
Ohio (73)
Oregon (2)
Pennsylvania (448)
Rhode Island (5)
South America (144)
South Carolina (6)
Southern California (1070)
Tennessee (25)
Texas (329)
United States (9343)
Utah (68)
Virginia (62)
Washington D.C. (5)
Washington State (175)
West Virginia (1)
Wisconsin (40)
80,472 Results for "45".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aptevo Therapeutics Announces Exercise of Existing Warrants and PIPE for $4.5 Million Gross Proceeds
August 12, 2026
·
6 min read
Press Releases
Kuros Biosciences delivers 45% H1 2026 year-over-year sales growth and increases overall profitability
August 13, 2026
·
11 min read
Press Releases
Sarepta Announces FDA Acceptance of sNDAs for AMONDYS 45® and VYONDYS 53®
June 30, 2026
·
17 min read
Press Releases
Aptevo Therapeutics Announces Closing of Existing Warrants Exercise and PIPE for $4.5 Million Gross Proceeds
August 14, 2026
·
6 min read
Press Releases
Micron Biomedical Secures $4.5 Million Federal Contract to Develop First Dissolvable Microarray Radiation/Nuclear Medical Countermeasure
July 27, 2026
·
7 min read
Press Releases
ALR Technologies Announces Strategic Acquisition of CGM Medical Technology for US$45 Million & 200M Shares
June 30, 2026
·
7 min read
Press Releases
Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients
June 11, 2026
·
7 min read
Press Releases
Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53®
March 19, 2026
·
15 min read
Press Releases
Moleculin CEO, Walter Klemp, Highlights 45 Subject Enrollment Milestone in Recent Virtual Investor “What This Means” Segment
June 4, 2026
·
4 min read
Press Releases
The Canadian Cancer Society welcomes Ontario’s move to lower colorectal cancer screening age to 45
May 8, 2026
·
2 min read
1 of 8,048
Next
